What's New

Last Posted: Mar 24, 2023

• An Unsupervised Machine Learning Approach to Evaluating the Association of Symptom Clusters With Adverse Outcomes Among Older Adults With Advanced Cancer: A Secondary Analysis of a Randomized Clinical Trial.
  Huiwen Xu et al. JAMA network open 2023 6(3) e234198
• Top advances of the year: Precision oncology.
  Aakash Desai et al. Cancer 2023 3
• Adjuvant durvalumab after concurrent chemoradiotherapy for patients with unresectable stage III NSCLC harbouring uncommon genomic alterations.
  Francesco Cortiula et al. European journal of cancer (Oxford, England : 1990) 2023 184172-178
• Laboratory blood test profiling reveals distinct biochemical and hemocyte features of KRAS mutated non-small cell lung cancer.
  Limin Ou et al. Journal of thoracic disease 2023 15(2) 365-375
• Towards the molecular era of discriminating multiple lung cancers
  Z Wang, Ebiomedicine, March 21, 2023
• Recalibration of a Deep Learning Model for Low-Dose Computed Tomographic Images to Inform Lung Cancer Screening Intervals.
  Rebecca Landy et al. JAMA network open 2023 6(3) e233273
• Using Recurrent Neural Networks to Extract High-Quality Information From Lung Cancer Screening Computerized Tomography Reports for Inter-Radiologist Audit and Feedback Quality Improvement.
  Yucheng Zhang et al. JCO clinical cancer informatics 2023 7e2200153
• Value of contrast-enhanced magnetic resonance imaging-T2WI-based radiomic features in distinguishing lung adenocarcinoma from lung squamous cell carcinoma with solid components >8 mm.
  Maoyuan Yang et al. Journal of thoracic disease 2023 15(2) 635-648
• Cytological Samples: An Asset for the Diagnosis and Therapeutic Management of Patients with Lung Cancer.
  Diane Frankel et al. Cells 2023 12(5)
• Palliative Radiotherapy for Non-metastatic Non-small-cell Lung Cancer: Impact of Blood Test Results on Survival.
  Carsten Nieder et al. In vivo (Athens, Greece) 2023 37(2) 771-776
• Risk and Protective Factors for Cancer Mortality Among United States Service Members and Veterans (2001-2018).
  Neika Sharifian et al. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2023
• Budget Impact Analysis of Comprehensive Genomic Profiling in Advanced Non-Small Cell Lung Cancer in Taiwan.
  Yi-Ling Tsai et al. Value in health regional issues 2023 3548-56
• Cost-effectiveness of camrelizumab plus chemotherapy vs. chemotherapy in the first-line treatment of non-squamous NSCLC: Evidence from China.
  Hongbin Dai et al. Frontiers in medicine 2023 101122731
• Cost-Effectiveness of Next-Generation Sequencing Versus Single-Gene Testing for the Molecular Diagnosis of Patients With Metastatic Non-Small-Cell Lung Cancer From the Perspective of Spanish Reference Centers.
  Edurne Arriola et al. JCO precision oncology 2023 7e2200546
• A Comprehensive Analysis of Programmed Cell Death-Associated Genes for Tumor Microenvironment Evaluation Promotes Precise Immunotherapy in Patients with Lung Adenocarcinoma
  Y Huang et al, J Per Med, March 7, 2023
• Brief Report: Clinical Outcomes Using Plasma-Based Molecular Profiling to Guide Treatment Decisions in Patients With Advanced NSCLC and Limited Access to Broad Tissue Testing.
  Miguel García-Pardo et al. Clinical lung cancer 2023
• Rare molecular subtypes of lung cancer.
  Guilherme Harada et al. Nature reviews. Clinical oncology 2023 2
• Association of Reported Candidate Monogenic Genes With Lung Cancer Risk.
  Andrew S Rifkin et al. Clinical lung cancer 2023
• Establishment of a Lymph Node Metastasis-Associated Prognostic Signature for Lung Adenocarcinoma.
  Jiao Yu et al. Genetics research 2023 20236585109
• Novel nutritional indicator as predictors among subtypes of lung cancer in diagnosis.
  Haiyang Li et al. Frontiers in nutrition 2023 101042047

More